Latest Share Chat

AMYT.L Share News (AMYT)

AMYT.L Information

There is currently no data for AMYT

Amryt Pharma Extends Lojuxta Licence Deal Into New Territories

Thu, 10th May 2018 13:25

LONDON (Alliance News) - Amryt Pharma PLC on Thursday said it has expanded its Lojuxta licence agreement with Aegerion Pharmaceuticals Inc into Russia, the Commonwealth of Independent States, and non-EU Balkan countries.

The original agreement with Aegerion covered the EU, the Middle East & North Africa, Switzerland, Turkey, and Israel.

Lojuxta is a treatment used for adults with the cholesterol disorder homozygous familial hypercholesterolaemia.

Amryt shares were down 1.0% on Thursday at 17.53 pence each.

More News

9 Dec 2020 09:47

Amryt Pharma gets approval for 'Lojuxta' in Brazil

(Sharecast News) - Biopharmaceutical company Amryt Pharma announced on Wednesday that it has received marketing authorisation approval from the Brazilian Health Regulatory Agency (ANVISA) for 'Lojuxta', or lomitapide.

8 Dec 2020 09:22

Amryt Pharma raising $40m for working capital, acquisitions

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma has entered into agreements to raise $40m, it announced on Tuesday, to fund working capital as well as potential acquisitions and licence deals.

29 Oct 2020 19:11

IN BRIEF: Amryt Pharma Posts Success From Filsuvez Trial

29 Oct 2020 16:09

Amryt shares rise on success of 'EASE' trial

(Sharecast News) - Biopharmaceutical company Amryt Pharma announced positive results from its pivotal phase 23 'EASE' trial of 'Filsuvez', or 'Oleogel-S10', previously 'AP101', on Thursday.

29 Oct 2020 16:02

UK Earnings, Trading Statements Calendar - Next 7 Days

19 Oct 2020 15:43

IN BRIEF: Amryt Pharma Signs Distribution Deal With Swixx Biopharma

19 Oct 2020 08:34

Amryt Pharma signs new distribution deal with Swixx BioPharma

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma announced the signing of a distribution agreement with Swixx BioPharma of Baar, Switzerland on Monday.

15 Sep 2020 22:08

UK TRADING UPDATE SUMMARY: Mortgage Advice Bureau Launches Later Life

9 Sep 2020 13:26

Amryt shares surge on Filsuvez phase 3 results

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma announced positive top-line results from its pivotal phase 3 'EASE' trial of 'Filsuvez' for the treatment of dystrophic and junctional epidermolysis bullosa on Wednesday.

9 Sep 2020 10:50